Witnesses

Information prior to the 40th Parliament is from notices of meetings. For the official record, please refer to the related minutes and transcripts.

There are limited electronic records available for the period prior to the 35th Parliament. For historical information, please contact: ctm@sen.parl.gc.ca or 1-800-267-7362

Date Org. Name/Title Studies & Bills Session  Note
May 12, 2004 Foreign Affairs and International Trade Canada Christopher Armstrong, Senior Advisor, HIV/AIDS, Human Rights, Humanitarian Affairs and International Women's Equality Division Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
May 12, 2004 Industry Canada Susan Bincoletto, Acting Director General, Marketplace Framework Policy Branch Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
May 12, 2004 Canadian International Development Agency Sandra Black, Director, Social Development Policies, Policy Branch Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
May 12, 2004 Canada's Research-Based Pharmaceutical Companies Adrienne Blanchard, Legal Counsel, Gowling, Lafleur and Henderson Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
May 12, 2004 Industry Canada Doug Clark, Senior Project Leader, Patent Policy Directorate Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
May 12, 2004 Industry Canada Éric Dagenais, Director, Patent Policy Directorate Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
May 12, 2004 The Honourable Bill Graham, P.C., M.P., Minister of Foreign Affairs Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
May 12, 2004 Canadian Generic Pharmaceutical Association Jim Keon, President Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
May 12, 2004 Health Canada David K. Lee, Directorate, Office of Patented Medicines and Liaison, Therapeutic Products Directorate, Health Products and Food Branch Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
May 12, 2004 Canada's Research-Based Pharmaceutical Companies Jean-François Leprince, President, Aventis Pharmaceutical, Chair, Rx&D Intellectual Property Committee Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act [Link to the notice of this meeting]
Legend
Audio Webcast
Audio Webcast
Video Webcast
Video Webcast
Meeting
Meeting
Minutes
Minutes
Transcripts
Transcripts
Interim
Interim